DistilINFO
Recent Posts
HomeProviderDigital Health Tools on TIME’s Best Inventions 2026

Digital Health Tools on TIME’s Best Inventions 2026

Tools

AI-powered imaging triage, a needle-free glucose sensor and a pharmacy kiosk inside a doctor’s office are among a dozen AI and digital health tools named to TIME’s Best Inventions of 2026 list, published Oct. 15. The annual list includes 300 inventions and 100 special mentions, judged on originality, efficacy, ambition and impact.

The healthcare picks reflect where digital health tools are gaining traction: AI that spots disease earlier, wearables that monitor patients continuously and consumer services that remove friction from care. Several of the honorees have received FDA clearance or published clinical evidence in the past year, giving health systems and payers a sense of which tools are moving from pilots into practice.

AI for Earlier Detection

Three honorees use AI to find disease before it is clinically obvious.

  • Aidoc CARE: In January, the FDA cleared Aidoc’s triage solution built on its CARE foundation model for 11 new acute indications, bringing the total to 14 in a single workflow. Aidoc called it the first FDA clearance of double-digit acute indications powered by one AI model. In the pivotal study, the new indications averaged 97 percent sensitivity and 98 percent specificity, according to the company.
  • EchoNext: Developed by Columbia University and NewYork-Presbyterian, EchoNext analyzes routine electrocardiograms to flag patients who need an echocardiogram. In a study published in Nature in July 2025, the model detected 77 percent of structural heart problems in a test set, versus 64 percent for cardiologists reading the same ECGs. In a real-world deployment covering nearly 85,000 patients, it flagged more than 7,500 as high risk.
  • C the Signs: The platform aims to help clinicians identify patients at risk of cancer sooner.

Ultrasound AI’s Delivery Date AI, which uses AI to predict pregnancy due dates, also made the list.

Monitoring and Safety in Hospitals

Several honorees target inpatient monitoring and safety, a priority for hospitals facing nursing shortages:

  • Artisight’s All-In-One Device, an AI-powered patient monitoring device for hospital rooms
  • Corsano’s medical-grade wearable, which tracks pulse rate, blood oxygen, respiratory rate, skin temperature and activity
  • Helpany’s Paul, a fall-prevention system designed to protect patient privacy

These tools reflect a broader push to extend nurses’ reach through continuous monitoring and virtual care rather than adding bedside staff.

Consumer Digital Health Tools

On the patient-facing side, TIME recognized digital health tools that move care into daily life.

Biolinq’s Shine received FDA de novo classification in September 2025 as the first fully autonomous, needle-free glucose sensor, according to the company. The forearm patch uses a microsensor array rather than an introducer needle and displays color-coded glucose feedback through LED lights, with or without a phone. It is initially marketed to adults with type 2 diabetes who do not use insulin.

Sequel Med Tech’s twiist is an automated insulin delivery system for people 6 and older with type 1 diabetes. FDA-cleared in 2024 and now available nationwide, it uses an algorithm based on the community-developed Tidepool Loop to adjust insulin based on continuous glucose monitor readings. The company says it can detect blockages up to nine times faster than other systems.

Hilo Core, from Hilo by Aktiia, launched in the U.S. in July. The system pairs a wrist-worn optical sensor with an FDA-cleared cuff to collect up to 35 blood pressure readings a day, including overnight. The wrist device is marketed as a wellness product while the company pursues further regulatory clearance.

Amazon Pharmacy’s kiosks, which began rolling out at One Medical offices in the Los Angeles area in December 2025, let patients pick up prescriptions minutes after an appointment. Each kiosk stocks medications based on its office’s prescribing patterns, and a pharmacist reviews each order remotely.

Ant Group’s AQ, an AI health app in China, rounds out the group. Ant said in September that AQ had reached 150 million users.

What the List Signals

TIME’s healthcare category also included drugs, such as Revolution Medicines’ daraxonrasib and Syndax’s Revuforj, but the 12 AI and digital health tools stand out for how many have cleared regulatory hurdles or shown results in practice.

For health system and payer leaders, the list points to three trends: foundation models that handle many conditions at once, continuous monitoring that moves beyond hospital walls, and convenience features from large retailers. The test for each will be whether early recognition turns into broad adoption, reimbursement and measurable outcomes.

For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.

Written by

The DistilINFO Editorial Team covers healthcare payer, provider, government health, life sciences and health AI news for more than 135,000 industry decision makers. Since 2016, DistilINFO has published daily briefings that summarize the developments that matter most to health plans, health systems and the organizations that serve them. Our stories are based on primary sources, including press releases, regulatory filings, CMS and HHS announcements, and peer-reviewed research, which we cite and link in every article. Questions or corrections: digital@distilinfo.com.

Latest comment